Regulation of hemostasis by singlet-oxygen (1ΔO2*)

Current Vascular Pharmacology

Volumn 2, Issue 4, 2004, Pages 357-362

  Stief, Thomas W ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOXETANE DERIVATIVE; ACETYLSALICYLIC ACID DERIVATIVE; ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; CARBENOID; CYSTEINE; FIBRIN; FIBRINOGEN; FIBRINOLYTIC AGENT; HYPOCHLORITE; LIPID; METHIONINE; OXIDIZING AGENT; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RADICAL; RETEPLASE; SINGLET OXYGEN; STAPHYLOKINASE; STREPTOKINASE; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR; TOSYLCHLORAMIDE SODIUM; UNINDEXED DRUG; UROKINASE; VON WILLEBRAND FACTOR;

ATHEROSCLEROSIS; BIOGENESIS; BLEEDING DISORDER; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD COMPONENT; BRAIN HEMORRHAGE; CHEMICAL REACTION; DOWN REGULATION; DRUG MECHANISM; ENDOTHELIUM CELL; GRANULOCYTE FUNCTION; HEMOSTASIS; HUMAN; LIGHT; NEUTROPHIL; OXIDATION; OXIDATION REDUCTION REACTION; PHOTON; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW; SPECTRUM; THROMBOCYTE; THROMBOCYTE FUNCTION; THROMBOSIS; THROMBUS; UPREGULATION;

ANIMALS; FIBRINOLYSIS; HEMOSTASIS; HUMANS; NEUTROPHILS; OXIDANTS; OXYGEN; SINGLET OXYGEN; THROMBOSIS;

EID: 4444295471     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570161043385420     Document Type: Review

References (90)

1. Murray CL, Lopez AD. Mortaliy by cause for eight regions of the world: global burden of disease study. The Lancet 1997; 349: 1269-1276.
2. Collen D, Lijnen HR. The fibrinolitic system in man. Critic Rev Hematol Oncol 1986; 4: 249-301.
3. Bick RL, Murano G. Physiology of thrombosis. Clin Lab Med 1994; 14: 677-707.
4. Stief TW, Hinz F, Kurz J, Doss MO, Kretschmer V. A simple functional screening assay for fibrinolysis parameters (FIPA). Thromb Res 2000; 97: 231-237.
5. Stief TW, Stief MH, Ehrenthal W, Darius M, Martin E. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single-chain urokinase. Thromb Res 1991; 64: 597-610.
6. Ichinose A, Fujikawa K, Suyama T. The activation of plasma pro-urokinase by kallikrein and its inactivation by thrombin. J Biol Chem 1986; 261: 3486-3489.
7. Dunn CJ. Goa KL. Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction. Am J Cardiovasc Drugs 2001; 1: 51-66.
8. Nordt, Bode C. Thrombolysis: newer thrombolytic agents and their roles in clinical medicine. Heart 2003; 89: 1358-62.
9. Khan IA, Gowda RM. Clinical perspectives and therapeutics of thrombolysis. Int J Cardiol 2003; 91: 115-27.
10. Baker WF Jr. Thrombolytic therapy: clinical applications. Hematol Oncol Clin North Am 2003; 17: 283-311.
11. Bell WR. Therapeutic agents - pharmacokinetics and pharmacodynamics. Rev Cardiovasc Med 2002; 3 suppl 2: S34-44.
12. Chen M, Arjomand H, Pollack CV Jr. The evolution of thrombolytic therapy and adjunctive antithrombotic regimens in acute ST-segment elevation myocardial infarction. Am J Emerg Med 2004; 22: 14-23.
13. Stief TW. The susceptibility of plasma to activation of fibrinolysis. Blood Coagul Fibrinolysis 1993; 4: 123-127.
14. Gurewich V. Fibrinolysis: an unfinished agenda. Blood Coagul Fibrinolysis 2000; 11: 401-408.
15. Warlow C. Stroke: killer clots and killer drugs. J Thromb Haemostas 2003; 1: 1422-8.
16. Doi H, Iwasaki H, Masbuchi Y, Nishigaki R, Horie T. Chemiluminescence associated with the oxidative metabolism of salicylic acid in rat liver microsomes. Chem Biol Interact 2002; 140: 109-19.
17. van Giezen JJ, Chung-A-Hing JE, Vegter CB, Bouma BN, Jansen JW. Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately. Thromb Haemost 1994; 72: 887-892.
18. Moir E, Booth NA, Bennett B, Robbie LA. Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA dependent mechanism. Br J Haematol 2001; 113: 72-80.
19. Moroz LA. Increased blood fibrinolytic activity after aspirin ingestion. N Engl J Med 1977; 296: 525-529.
20. Ghezzo F, Trinchero T, Pegoraro L. Effects of aspirin treatment upon fibrinolytic activity of peripheral blood granulocytes. Acta Haematol 1981; 65: 229-332.
21. Grau E, Moroz LA. Fibrinolytic activity of normal human blood monocytes. Thromb Res 1989; 53: 145-162.
22. Astrup T. Fibrinolysis: past and present, a reflection of fifty years. Semin Thromb Hemost 1991; 161-174.
23. Langleben D, Moroz LA. Interspecies variation in the cellular phase of blood fibrinolytic activity. Proc Soc Exp Biol Med 1991; 196: 270-272.
24. Adams SA, Kelly SL, Kirsch RE, Robson SC, Shephard EG. Role of neutrophil membrane proteases in fibrin degradation. Blood Coagul Fibrinolysis 1995; 6: 693-702.
25. Adams SA, Kelly SL, Kirsch RE, Shephard EG. Digestion of 125 I-labelled plasmin-derived fibrin degradation products by neutrophil lysosomal enzymes. Blood Coagul Fibrinolysis 1998; 9: 307-313.
26. Sarma J, Laan CA, Alam S, Jha A, Fox KAA, Dransfield I. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002. 105: 2166-2171.
27. Ruf A, Schlenk RF, Maras A, Morgenstern E, Patscheke H. Contact-induced neutrophil activation by platelets in human cell suspensions and whole blood. Blood 1992; 80: 1238-1246.
28. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol 1990; 106: 391-399.
29. Gyetko MR, Sud S, Kendall T, Fuller JA, Newstead MW, Standiford TJ. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary pseudomonas aeruginosa infection. J Immunol 2000; 165: 1513-1519.
30. Dano K, Andreasen P, Grondahl-Hansen J, Kristensen P, Nielsen L, Skriver L. Plasminogen activation, tissue degradation, and cancer. Adv Cancer Research 1985; 44: 139-266.
31. Sitrin RG, Todd III RF, Albrecht E, Gyetko MR. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 1996; 97: 1942-1951.
32. Cao D, Mizukami IF, Garni-Wagner A, Kindzelskii AL, Todd III RF, Boxer LA, Petty HR. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. J Immunol 1995; 154: 1817-1829.
33. Gyetko MR, Sitrin RG, Fuller JA, Todd III RF, Petty H, Standiford TJ. Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leukocyte Biol 1995; 58: 533-538.
34. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-424.
35. Pepper MS, Sappino AP, Stocklin R, Montesano R, Orci L, Vassalli JD. Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 1993; 122: 673-684.
36. Hellewell PG, Young SK, Henson PM, Worthen GS. Disparate role of the b2-integrin CD18 in the local accumulation of neutrophils in pulmonary and cutaneous inflammation in the rabbit, Am J Respir Cell Mol Biol 1994; 10: 391-398.
37. Doershuk CM, Winn RK, Rice L, Coxson HO, Harlan JM. CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation in rabbits. J Immunol 1990; 144: 2327-2333.
38. Harlan JM. Leukocyte-endothelial interactions. Blood 1985; 65: 513-525.
39. Stief TW, Fu K, Ramaswamy A, Fareed J. Singlet oxygen induces selective thrombolysis in vivo by massive granulocyte infiltration into the thrombus. 43. GTH Congress, Mannheim, 24.-27.2.1999, Ann Hematol 1999;78: A32.
40. 2/hv). Clin Appl Thrombosis/Hemostasis 2000; 6: 22-30.
41. Stief TW. The blood fibrinolysis/deep-sea analogy: a hypothesis on the cell signals singlet oxygen/photons as natural antithrombotics. Thromb Res 2000; 99: 1-207.
42. McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001; 86: 746-56.
43. Vercellotti GM, Severson SP, Duane P, Moldow CF. Hydrogen peroxide alters signal transduction in human endothelial cells. J Lab Clin Med 1991; 117: 15-24.
44. Bach TL, Barsigian C, Yaen CH, Martinez J. Endothelial cell VE-cadherin functions as a receptor for the beta 15-42 sequence of fibrin. J Biol Chem 1998; 273: 30719-30728.
45. Wright SD, Weitz JI, Huang AJ, Levin SM, Silverstein SC, Loike JD. Complement receptor type three (CD 11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci USA 1988; 85: 7734-7738.
46. Perez RL, Roman J. Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications of pulmonary inflammation. J Immunol 1995; 154: 1879-1887.
47. Trezzini C, Schalch L, Jungi TW. The triggering of fibrinogen receptors on mononuclear phagocytes of healthy subjects and of a thrombasthenia Glanzmann patient promotes the generation of reactive oxygen species. Blood Coagul Fibrinolysis 1990; 1: 363-373.
48. Sigal A, Bleijs DA, Grabovsky V, Vliet SJ, Dwir O, Figdor CG, van Kooyk Y, Alon R. The LFA-1 integrin supports rolling adhesions on ICAM-1 under physiological shear flow in a permissive cellular environment. J Immunol 2000; 165: 442-52.
49. Entman ML, Youker K, Shappell SB, Siegel C, Rothlein R, Dreyer WJ, Schmalstieg FC, Smith CW. Neutrophil adherence to isolated adult canine myocytes. Evidence for a CD18-dependent mechanism. J Clin Invest 1990; 85: 1497-1506.
50. Shapell SB, Toman C, Anderson DC, Taylor AA, Smith CW. Adherence-dependent neutrophil hydrogen peroxide secrection is mediated by Mac-1 (CD11/18). J Immunol 1989; 144: 2702-2711.
51. Grether-Beck S, Olaizola-Horn S, Schmitt H, Grewe M, Jahnke A, Johnson JP, Briviba K, Sies H, Krutmann J. Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen- induced expression of the human intercellular adhesion molecule 1 gene. Proc Natl Acad Sci USA 1996; 93: 14586-14591.
52. Stief TW, Heimburger N. Inactivation of serine protease inhibitors (serpins) in human plasma by reactive oxidants. Biol Chem 1988; 369: 1337-1342.
53. Stief TW, Martin E, Caso F, Rodriguez JM. Oxidation susceptibility of plasminogen activator inhibitors of human plasma. Thromb Res 1990; 60: 177-180.
54. 2-macroglobulin. Thromb Res 2000; 98: 541-547.
55. Stief TW. Oxidized fibrin stimulates the activation of pro-urokinase and is the preferential substrate of human plasmin. Blood Coagul Fibrinolysis 1993; 4: 117-122.
56. Stief TW, Martin E, Jimenez J, Digon J, Rodriguez JM. Effect of oxidants on proteases of the fibrinolytic system: possible role for methionine residues in t-PA/fibrin interaction. Thromb Res 1991; 61: 191-200.
57. 2)- oxidized fibrinogen into a soluble t-PA cofactor. Ann Hematol 2001; 80: 189-194.
58. Stief TW, Lenz P, Becker U, Heimburger N. Determination of plasminogen activator inhibitor (PAI) capacity of human plasma in presence of oxidants: a novel principle. Thromb Res 1988; 50: 559-573.
59. Stief TW. A direct approach in fibrinolysis diagnostic: mimicry of the leukocyte attack by oxidants. Thromb Res 1989; 56: 213-220.
60. Stief TW, Kurz J, Doss MO, Fareed J. Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood. Thromb Res 2000; 97: 473-480.
61. 2) disrupts platelet aggregates. Thromb Res 2001; 104: 361-370.
62. Stief TW, Jeske WP, Walenga J, Schultz C, Kretschmer V, Fareed J. Singlet oxygen inhibits agonist-induced P-selectin expression and formation of platelet aggregates. Clin Appl Thrombosis/Hemostasis 2001; 7: 219-224.
63. Colucci M, Paramo JA, Stassen JM, Collen D. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components. J Clin Invest 1986; 78: 138-144.
64. Stief TW. Nonradical excited oxygen species induce selective thrombolysis in vivo. Thromb Res 1991; 62: 147-163.
65. Babior BM. NADPH-oxidase: an update. Blood 1999; 93: 1464-1476.
66. Weiss SJ. Tissue destruction by neutrophils. New Engl J Med 1989; 320: 365-376.
67. Nathan CF. Neutrophil activation on biological surfaces. Massive release of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987; 80: 1550-60.
68. Morita Y, Clemens MG, Miller LS, Rangan U, Kondo S, Miyasaka M, Yoshikawa T, Bulkley GB. Reactive oxidants mediate TNF-alpha induced leukocyte adhesion to rat mesenteric venular endothelium. Am J Physiol 1995; 269: H833-842.
69. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-2315.
70. Takahashi M, Nagao T, Imazeki Y, Matsuzaki K, Minamitani H. Role of reactive oxygen species in monocyte activation induced by photochemical reactions during photodynamic therapy. Front Med Biol Eng 2002; 11: 279-94.
71. Osterud B, Rao LVM, Olsen JO. Induction of tissue factor expression in whole blood: lack of evidence for the presence of tissue factor expression in granulocytes. Thromb Haemostas 2000; 83: 861-7.
72. Schaub RG, Simmons CA, Koets MH, Romano PJ 2nd, Steward GJ. Early events in the formation of a venous thrombus following local trauma and stasis. Lab Invest 1984; 51: 218-224.
73. Downing LJ, Strieter RM, Kadell AM, Wilke CA, Brown SL, Wrobleski SK, Burdick MD, Hulin MS, Fowlkes JB, Greenfield LJ, Wakefield TW. Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation. ASAIO J 1996; 42: M677-682.
74. Wentworth P Jr, Nieva J, Takeuchi C, Galve R, Wentworth AD, Dilley RB, DeLaria GA, Saven A, Babior BM, Janda KD, Eschenmoser A, Lerner RA. Evidence for ozone formation in human atheroscleronic arteries. Science 2003; 302: 1053-1056.
75. Rosen H, Klebanoff SJ. Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system. J Biol Chem 1977; 252: 4803-4810.
76. Cadenas E, Sies H. Low level chemiluminescence as an indicator of singlet oxygen in biological systems. Methods Enzymol 1984; 105: 221-231.
77. Cadenas E, Sies H. Oxidative stress: excited oxygen species and enzyme activity. Adv Enzyme Regul 1985; 23: 217-237.
78. Tarr M, Valenzeno DP. Singlet oxygen: the relevance of extracellular production mechanism to oxidative stress in vivo. Photochem Photobiol Sci 2003; 2: 355-61.
79. Klotz LO, Kroncke KD, Sies H. Singlet oxygen-induced signalling effects in mammalian cells. Photochem Photobiol Sci 2003; 2: 88-94.
80. 18O-labeled linoleic acid hydroperoxide and monomol light emission measurements. J Am Chem Soc 2003; 125: 6172-9.
81. Warso MA, Lands WE. Presence of lipid hydroperoxides in human plasma. J Clin Invest 1985; 75: 667-71.
82. Petrone WF, English DK, Wong K, McCord JM. Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc Natl Acad Sci USA 1980; 77: 1159-63.
83. Devasagayam TP, Kamat JP. Biological significance of singlet oxygen. Indian J Exp Biol 2002; 40: 680-92.
84. Zhuang S, Kochevar IE. Singlet oxygen-induced activation of Akt/protein kinase B is independent of growth factor receptors. Photochem Photobiol 2003; 78: 361-71.
85. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 2003; 15: 247-54.
86. Arisawa F, Tatsuzawa H, Kambayashi Y, Kuwano H, Fujimori K, Nakano M. MCLA-dependent chemiluminescence suggests that singlet oxygen plays a pivotal role in myeloperoxidase-catalysed bactericidal action in neutrophil phagosomes. Luminescence 2003; 18: 229-38.
87. Stief TW. The physiology and pharmacology of singlet oxygen. Med Hypotheses 2003; 60: 567-572.
88. Moan J, Peng Q. An outline of the hundred-year history of PDT. Anticancer Res 2003; 23: 3591-600.
89. Stief TW. Is singlet oxygen antiatherosclerotic ? (letter) Am J Pathol 2001; 158: 781-2.
90. Campbell AK. Living light: biochemistry, applications. Essays Biochem 1989; 24: 41-81.